ADC Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.

About ADCT

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. 

CEO
Ameet Mallik
CEOAmeet Mallik
Employees
265
Employees265
Headquarters
Epalinges, Vaud
HeadquartersEpalinges, Vaud
Founded
2011
Founded2011
Employees
265
Employees265

ADCT Key Statistics

Market cap
132.50M
Market cap132.50M
Price-Earnings ratio
-0.80
Price-Earnings ratio-0.80
Dividend yield
—
Dividend yield—
Average volume
246.36K
Average volume246.36K
High today
$1.36
High today$1.36
Low today
$1.29
Low today$1.29
Open price
$1.34
Open price$1.34
Volume
121.24K
Volume121.24K
52 Week high
$5.17
52 Week high$5.17
52 Week low
$1.05
52 Week low$1.05

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.